GLOBAL PHARMA GROUP: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GLOBAL PHARMA GROUP
Largest movements
- Stocks and contracts -€624,681
down €624,681 (-64.1%), from €974,089 to €349,408
- Cash -€74,424
down €74,424 (-79.1%), from €94,140 to €19,716
mainly Short-term financial debts (-€526,800) and Tax, wage and social debts (-€250,512)
- Short-term financial debts -€526,800
down €526,800 (-100%), from €526,800 to €0
- Tax, wage and social debts -€250,512
down €250,512 (-100%), from €250,512 to €0
- Other debts +€115,013
up €115,013 (+13.3%), from €866,372 to €981,385
- Trade debts -€53,509
down €53,509 (-81.7%), from €65,509 to €12,000
- Profit (loss) carried forward +€17,441
up €17,441 (+2.7%), from -€648,907 to -€631,466
- Gross operating margin +€405,123
up €405,123, from -€373,910 to €31,213
- Financial charges -€113,115
down €113,115 (-90.1%), from €125,525 to €12,410
- Other operating charges -€30,037
down €30,037 (-95.7%), from €31,400 to €1,362
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,068,375 | €369,993 | -€698,382 | -65.4% |
| Current assets | 29/58 | €1,068,375 | €369,993 | -€698,382 | -65.4% |
| Stocks and contracts in progress | 3 | €974,089 | €349,408 | -€624,681 | -64.1% |
| Stocks | 30/36 | €974,089 | €349,408 | -€624,681 | -64.1% |
| Amounts receivable within one year | 40/41 | €146 | €869 | +€723 | +495% |
| Trade receivables | 40 | €146 | €0 | -€146 | -100% |
| Other amounts receivable | 41 | - | €869 | +€869 | |
| Cash at bank and in hand | 54/58 | €94,140 | €19,716 | -€74,424 | -79.1% |
| Deferred charges and accrued income | 490/1 | €0 | - | = | |
| Total equity and liabilities | 10/49 | €1,068,375 | €369,993 | -€698,382 | -65.4% |
| Equity | 10/15 | -€640,834 | -€623,393 | +€17,441 | +2.7% |
| Contributions | 10/11 | €6,210 | €6,210 | = | 0.0% |
| Reserves | 13 | €1,863 | €1,863 | = | 0.0% |
| Distributable reserves | 133 | €1,863 | €1,863 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€648,907 | -€631,466 | +€17,441 | +2.7% |
| Amounts payable | 17/49 | €1,709,209 | €993,385 | -€715,823 | -41.9% |
| Amounts payable within one year | 42/48 | €1,709,193 | €993,385 | -€715,807 | -41.9% |
| Financial debts | 43 | €526,800 | €0 | -€526,800 | -100% |
| Credit institutions | 430/8 | €526,800 | €0 | -€526,800 | -100% |
| Trade debts | 44 | €65,509 | €12,000 | -€53,509 | -81.7% |
| Suppliers | 440/4 | €65,509 | €12,000 | -€53,509 | -81.7% |
| Taxes, remuneration and social security | 45 | €250,512 | €0 | -€250,512 | -100% |
| Taxes | 450/3 | €250,512 | €0 | -€250,512 | -100% |
| Other amounts payable | 47/48 | €866,372 | €981,385 | +€115,013 | +13.3% |
| Accrued charges and deferred income | 492/3 | €16 | €0 | -€16 | -100% |
| Other operating charges | 640/8 | €31,400 | €1,362 | -€30,037 | -95.7% |
| Gross operating margin | 9900 | -€373,910 | €31,213 | +€405,123 | |
| Operating profit (loss) | 9901 | -€405,309 | €29,851 | +€435,161 | |
| Financial income | 75/76B | €87 | €0 | -€87 | -100% |
| Recurring financial income | 75 | €87 | €0 | -€87 | -100% |
| Financial charges | 65/66B | €125,525 | €12,410 | -€113,115 | -90.1% |
| Recurring financial charges | 65 | €125,525 | €12,410 | -€113,115 | -90.1% |
| Profit (loss) for the period before taxes | 9903 | -€530,747 | €17,441 | +€548,189 | |
| Profit (loss) for the period | 9904 | -€530,747 | €17,441 | +€548,189 | |
| Profit (loss) for the period to be appropriated | 9905 | -€530,747 | €17,441 | +€548,189 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.